Molecular Imaging: Page 121

IBA to acquire full interest in CIS Bio

By AuntMinnieEurope.com staff writers

Belgian radiopharmaceutical firm Ion Beam Applications (IBA) plans to expand its stake in French biomedical technology company CIS Bio International to own 100% of the company.

September 13, 2007

Carestream launches new PACS software

By AuntMinnieEurope.com staff writers

Carestream Health of Rochester, NY, this week introduced advanced features for its PACS at the European Society of Therapeutic Radiology and Oncology (ESTRO) meeting in Barcelona, Spain.

September 3, 2007

IBA gets OK for U.K. PET facility

By AuntMinnieEurope.com staff writers

Radioisotope manufacturer Ion Beam Applications (IBA) has received approval from U.K. officials to begin the manufacture of radiopharmaceuticals at its new PET production facility in Dinnington, South Yorkshire.

July 2, 2007

IBA begins European I-124 shipments

By AuntMinnieEurope.com staff writers

Radioisotope manufacturer Ion Beam Applications (IBA) has begun delivery of iodine-124 to PET centers in Europe.

June 3, 2007

U.K. widens probe into nuclear plant autopsy tests

By Reuters Health

LONDON (Reuters), Apr 27 - Britain widened an investigation on Thursday into the collection of human body parts for scientific tests at nuclear plants, after authorities said more sites may have been involved than initially disclosed. The government launched a probe last week after discovering that tissue was taken from the bodies of former workers at a state-owned nuclear plant who died between 1962 and 1991.

April 26, 2007

IBA opens new radiotracer site

By AuntMinnieEurope.com staff writers

Radioisotope manufacturer Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium, has opened a new facility for radiopharmaceutical R&D and production in Belgium.

April 19, 2007

Britain investigates removal of nuclear body parts

By Reuters Health

LONDON (Reuters), Apr 18 - Unions representing workers in the nuclear industry say as many as 70 people who worked at the Sellafield nuclear fuel reprocessing plant in northern England and other nuclear facilities may have had tissue, bones, and organs removed for radiological testing.

April 17, 2007

ART lands CE Mark

By AuntMinnieEurope.com staff writers

Canadian optical molecular imaging developer ART Advanced Research Technologies has received the European CE Mark for its SoftScan optical breast imaging device.

February 7, 2007

Study: PET posts double-digit gains in Western Europe

By AuntMinnieEurope.com staff writers

A study by healthcare consultants Medical Options of London estimated that 491,000 patient studies will be performed using PET in Western Europe in 2006.

January 21, 2007

Philips, Bioscan partner on NanoSPECT marketing

By AuntMinnieEurope.com staff writers

Philips Medical Systems has signed an agreement giving it the rights to co-market and co-distribute molecular imaging developer Bioscan's NanoSPECT and NanoSPECT/CT devices.

January 1, 2007

PET scans track breast cancer response to chemotherapy

By Reuters Health

NEW YORK (Reuters Health), Dec 25 - Positron emission tomography (PET) following infusion of F-18 fluorodeoxyglucose (FDG) is an effective means of predicting response to neoadjuvant chemotherapy in patients with breast cancer, French researchers report in the December 1st issue of the Journal of Clinical Oncology.

December 24, 2006

IBA starts shipments from new Italian facility

By AuntMinnieEurope.com staff writers

Belgian nuclear medicine products firm Ion Beam Application (IBA) of Louvain-la-Neuve has begun distribution of PET radiopharmaceuticals from a facility in Rome, Italy.

December 10, 2006

Page 121 of 122